DK0831779T4 - Fremgangsmåde til fremstilling af liposompræparat - Google Patents

Fremgangsmåde til fremstilling af liposompræparat

Info

Publication number
DK0831779T4
DK0831779T4 DK96918002T DK96918002T DK0831779T4 DK 0831779 T4 DK0831779 T4 DK 0831779T4 DK 96918002 T DK96918002 T DK 96918002T DK 96918002 T DK96918002 T DK 96918002T DK 0831779 T4 DK0831779 T4 DK 0831779T4
Authority
DK
Denmark
Prior art keywords
liposome preparation
portions
liposome
preparing liposome
encapsulated
Prior art date
Application number
DK96918002T
Other languages
Danish (da)
English (en)
Other versions
DK0831779T3 (da
Inventor
Carl L Alving
Roberta R Owens
Nabila M Wassef
Original Assignee
U S Dept Of The Army
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23888222&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0831779(T4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by U S Dept Of The Army filed Critical U S Dept Of The Army
Application granted granted Critical
Publication of DK0831779T3 publication Critical patent/DK0831779T3/da
Publication of DK0831779T4 publication Critical patent/DK0831779T4/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1277—Preparation processes; Proliposomes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
DK96918002T 1995-06-07 1996-06-06 Fremgangsmåde til fremstilling af liposompræparat DK0831779T4 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/475,581 US6007838A (en) 1995-06-07 1995-06-07 Process for making liposome preparation
PCT/US1996/008622 WO1996040063A1 (en) 1995-06-07 1996-06-06 Process for making liposome preparation

Publications (2)

Publication Number Publication Date
DK0831779T3 DK0831779T3 (da) 2001-10-08
DK0831779T4 true DK0831779T4 (da) 2005-06-06

Family

ID=23888222

Family Applications (1)

Application Number Title Priority Date Filing Date
DK96918002T DK0831779T4 (da) 1995-06-07 1996-06-06 Fremgangsmåde til fremstilling af liposompræparat

Country Status (12)

Country Link
US (1) US6007838A (2)
EP (1) EP0831779B2 (2)
JP (1) JP2000514035A (2)
AT (1) ATE203898T1 (2)
AU (1) AU699055B2 (2)
CA (1) CA2223808A1 (2)
DE (1) DE69614385T3 (2)
DK (1) DK0831779T4 (2)
ES (1) ES2159358T3 (2)
IL (1) IL122486A (2)
PT (1) PT831779E (2)
WO (1) WO1996040063A1 (2)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4575592B2 (ja) * 1997-11-14 2010-11-04 パシラ ファーマシューティカルズ インコーポレーテッド 多小胞リポソームの製造
WO2001070591A1 (en) 2000-03-21 2001-09-27 Suzanne Jaffe Stillman Infusion packet with useful and decorative elements, support member, delivery system and method
US7115297B2 (en) 2000-02-22 2006-10-03 Suzanne Jaffe Stillman Nutritionally fortified liquid composition with added value delivery systems/elements/additives
US8178150B2 (en) 2000-02-22 2012-05-15 Suzanne Jaffe Stillman Water containing soluble fiber
US7892586B2 (en) 2001-02-22 2011-02-22 Suzanne Jaffe Stillman Water containing soluble fiber
US8642051B2 (en) 2000-03-21 2014-02-04 Suzanne Jaffe Stillman Method of hydration; infusion packet system(s), support member(s), delivery system(s), and method(s); with business model(s) and Method(s)
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
US7223406B2 (en) 2000-07-21 2007-05-29 The Regents Of The University Of California Methods and compositions for preventing and treating male erectile dysfunction and female sexual arousal disorder
WO2002007757A2 (en) 2000-07-21 2002-01-31 Lue Tom F Prevention and treatment of sexual arousal disorders
US20040082521A1 (en) * 2002-03-29 2004-04-29 Azaya Therapeutics Inc. Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
US20030219696A1 (en) * 2002-05-23 2003-11-27 Moreland Gerald W. Method and apparatus for preventing backflow in dental saliva evacuators
EP1519714B1 (en) * 2002-06-28 2010-10-20 Protiva Biotherapeutics Inc. Method and apparatus for producing liposomes
CA2493124C (en) 2002-08-02 2014-04-29 Glaxosmithkline Biologicals S.A. Vaccine
US7179484B2 (en) * 2002-11-06 2007-02-20 Azaya Therapeutics, Inc. Protein-stabilized liposomal formulations of pharmaceutical agents
CN103989633A (zh) 2005-07-27 2014-08-20 普洛体维生物治疗公司 制造脂质体的系统和方法
WO2007049279A2 (en) * 2005-10-26 2007-05-03 Yissum Research Development Company Of The Hebrew University Of Jerusalem A liposomal combination and uses thereof
DE602007003596D1 (de) 2006-06-12 2010-01-14 Glaxosmithkline Biolog Sa Impfstoff
NO329127B1 (no) * 2006-09-12 2010-08-30 Epitarget As Sporbart partikulaert materiale for legemiddelavlevering omfattende et matriseeller membranmateriale, et legemiddel, og et T1- og et T2*- magnetisk resonanskontrastmiddel
JP2012526133A (ja) 2009-05-05 2012-10-25 ベイポジェニックス インコーポレイテッド 炎症を低減させるための新規揮発性麻酔薬製剤およびその使用法
WO2011119920A2 (en) 2010-03-25 2011-09-29 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
SMT201800284T1 (it) 2011-06-10 2018-07-17 Univ Oregon Health & Science Glicoproteine cmv e vettori ricombinanti
EP2586461A1 (en) 2011-10-27 2013-05-01 Christopher L. Parks Viral particles derived from an enveloped virus
ES2631608T3 (es) 2012-06-27 2017-09-01 International Aids Vaccine Initiative Variante de la glicoproteína Env del VIH-1
CN113712911A (zh) 2013-03-15 2021-11-30 维普詹尼克斯公司 新型镇痛组合物
EP2848937A1 (en) 2013-09-05 2015-03-18 International Aids Vaccine Initiative Methods of identifying novel HIV-1 immunogens
EP2873423B1 (en) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Soluble hiv-1 envelope glycoprotein trimers
US9392814B2 (en) 2014-06-06 2016-07-19 Nicholas J. Singer Delivery system for drinks
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
USD773313S1 (en) 2015-06-23 2016-12-06 Nicholas J. Singer Package
WO2018201022A1 (en) * 2017-04-28 2018-11-01 The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. Compositions and methods for vaccine delivery
CN114126600B (zh) * 2020-01-20 2024-03-08 广州谷森制药有限公司 三苯乙酸维兰特罗的脂质体制剂
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
GB2627096A (en) 2021-10-14 2024-08-14 Pacira Pharmaceuticals Inc Bupivacaine multivesicular liposome formulations and uses thereof
US12251468B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12246092B1 (en) 2024-05-20 2025-03-11 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2408387A2 (fr) † 1975-06-30 1979-06-08 Oreal Compositions a base de dispersions aqueuses de spherules lipidiques
EP0256119A4 (en) * 1986-02-10 1988-08-23 Liposome Technology Inc MAINTAINED LIPOSOME DELIVERY SYSTEM.
US4752425A (en) † 1986-09-18 1988-06-21 Liposome Technology, Inc. High-encapsulation liposome processing method
DE4124252A1 (de) * 1991-07-22 1993-01-28 Knoll Ag Verfahren zur herstellung einer sterilfiltrierbaren wirkstoffloesung
US5631237A (en) † 1992-12-22 1997-05-20 Dzau; Victor J. Method for producing in vivo delivery of therapeutic agents via liposomes
FR2714601B1 (fr) † 1993-12-30 1996-02-09 Oreal Composition dépigmentante pour le traitement simultané des couches superficielles et profondes, son utilisation.

Also Published As

Publication number Publication date
PT831779E (pt) 2001-11-30
DE69614385T2 (de) 2002-05-23
IL122486A0 (en) 1998-06-15
US6007838A (en) 1999-12-28
CA2223808A1 (en) 1996-12-19
IL122486A (en) 2000-07-16
DK0831779T3 (da) 2001-10-08
EP0831779B1 (en) 2001-08-08
DE69614385D1 (de) 2001-09-13
AU699055B2 (en) 1998-11-19
WO1996040063A1 (en) 1996-12-19
EP0831779A1 (en) 1998-04-01
AU6036596A (en) 1996-12-30
EP0831779B2 (en) 2005-01-19
ES2159358T3 (es) 2001-10-01
JP2000514035A (ja) 2000-10-24
DE69614385T3 (de) 2005-05-25
ATE203898T1 (de) 2001-08-15

Similar Documents

Publication Publication Date Title
DK0831779T3 (da) Fremgangsmåde til fremstilling af liposompræparat
ES8801118A1 (es) Un metodo para preparar liposomas a base de un fosfolipeno un agente hidratante y un farmaco encapsulado.
DK86988A (da) Liposompraeparat og anvendelse deraf
GB2015464B (en) Method of encapsulating biologically active materials in lipid vesicles
ES8607906A1 (es) Procedimiento para la obtencion de composiciones farmaceuti-cas conteniendo liposomas unilamilares
AU4711296A (en) Method for loading lipid vesicles
ES2088385T3 (es) Formulaciones de liposomas con una elevada relacion agente antineoplasico/lipido.
GEP20022734B (en) Pharmaceutical Preparation Comprising Lyophilized Liposomes Encapsulating an Active Principle Which Is Highly Insoluble in Water, and the Process for Preparing the Said Preparation
ZA792284B (en) Structural analogs of natural phosphatides processes for their preparation,and pharmaceutical preparations thereof
DK629388A (da) Fremgangsmaade til fremstilling af amphotericin b liposome
ES2077904T3 (es) Obtencion y uso de preparados estables de liposomas en forma de pequeñas particulas.
NZ503293A (en) Liposomal camptothecin formulations also comprising at least one phospholipid
EP0728476A4 (en) LIPOSOME COMPOSITION
PT98371A (pt) Processo para a preparacao de derivados 6-alcoxi de arabinofuranosil-guanina e de composicoes farmaceuticas que os contem
ATE238769T1 (de) Unilamellare liposomenzubereitungen mit hohem wirkstoffanteil
PT95697A (pt) Processo para a preparacao de composicoes farmaceuticas contendo substancias antiandrogenicamente activas
IL56499A (en) Liposome medicament delivery systems,their preparation and pharmaceutical compositions containing them
NO306762B1 (no) Anvendelse av lanolinderivater sammen med polyetylenglykoletere, blanding derav og transdermalt terapeutisk system
EP0198765A3 (en) Preparation of liposomes
DE69122810D1 (de) Liposomen
DE3878696D1 (de) Liposome, ihre herstellung und anwendung als vektor von arzneimitteln.
NO171295C (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat i form av et biologisk aktivt konjugert protein
IT8820260A0 (it) 1,2_di_0_acetil_glicero_3_difosfato di l_carnitina e degli esteri della l_carnitina, procedimento per la sua preparazione e formulazioni farmaceutiche che li contengono.
IT8820071A0 (it) 1,2_di_0_acetil glicero fosfato di l_carnitina e degli esteri della carnitina procedimento per la sua preparazione e formulazioni farmaceutiche che li contengono.
PL287608A1 (en) Method of obtaining stable nitroglycerin dispersion in production of pharmaceutical preparations in particular in the form of tablets